Opthea Limited (OPT)
USD 3.41
(1.49%)
USD 3.41
(1.49%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -191.84 Million USD | 14.14% |
| 2023 | -146.79 Million USD | -52.43% |
| 2022 | -96.3 Million USD | -145.23% |
| 2021 | -39.26 Million USD | -66590.49% |
| 2020 | 59.06 Thousand USD | -47.5% |
| 2019 | 112.49 Thousand USD | 100.49% |
| 2018 | -23.17 Million USD | -210.53% |
| 2017 | -7.46 Million USD | -26.85% |
| 2016 | -5.88 Million USD | 13.19% |
| 2015 | -6.77 Million USD | -5.27% |
| 2014 | -6.43 Million USD | -1.29% |
| 2013 | -6.35 Million USD | 29.4% |
| 2012 | -9 Million USD | 31.42% |
| 2011 | -13.12 Million USD | -79.51% |
| 2010 | -7.31 Million USD | -8.12% |
| 2009 | -6.76 Million USD | 14.6% |
| 2008 | -7.91 Million USD | 34.92% |
| 2007 | -12.16 Million USD | -365.08% |
| 2006 | -2.61 Million USD | -49.62% |
| 2005 | -1.74 Million USD | -39.31% |
| 2004 | -1.25 Million USD | 37.72% |
| 2003 | -2.01 Million USD | 1.59% |
| 2002 | -2.04 Million USD | -31129.23% |
| 2001 | -6557.87 USD | 98.0% |
| 2000 | -328.56 Thousand USD | 33.21% |
| 1999 | -491.94 Thousand USD | -22.43% |
| 1998 | -401.8 Thousand USD | -106.82% |
| 1997 | -194.27 Thousand USD | -17.97% |
| 1996 | -164.67 Thousand USD | -70.33% |
| 1995 | -96.68 Thousand USD | -15.75% |
| 1994 | -83.52 Thousand USD | -66.47% |
| 1993 | -50.17 Thousand USD | -52.79% |
| 1992 | -32.83 Thousand USD | 37.26% |
| 1991 | -52.33 Thousand USD | -735.92% |
| 1990 | -6261.03 USD | -209.15% |
| 1989 | 5736.20 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -94.61 Million USD | 0.0% |
| 2024 FY | -192.68 Million USD | -31.26% |
| 2024 Q4 | -191.84 Million USD | 0.0% |
| 2023 FY | -146.79 Million USD | -52.43% |
| 2023 Q4 | -70.8 Million USD | 0.0% |
| 2023 Q2 | -78.85 Million USD | 0.0% |
| 2022 FY | -96.3 Million USD | -145.23% |
| 2022 Q4 | -57.19 Million USD | 0.0% |
| 2022 Q2 | -39.28 Million USD | 0.0% |
| 2021 FY | -39.26 Million USD | -66590.49% |
| 2021 Q2 | -19.06 Million USD | 0.0% |
| 2021 Q4 | -20.6 Million USD | 0.0% |
| 2020 FY | 59.06 Thousand USD | -47.5% |
| 2020 Q4 | -8.92 Million USD | 0.0% |
| 2020 Q2 | -8.11 Million USD | 0.0% |
| 2019 FY | 112.49 Thousand USD | 100.49% |
| 2019 Q2 | -14.33 Million USD | 0.0% |
| 2019 Q4 | -12.08 Million USD | 0.0% |
| 2018 Q4 | -12.69 Million AUD | 0.0% |
| 2018 Q2 | -10.44 Million USD | 0.0% |
| 2018 FY | -23.17 Million USD | -210.53% |
| 2017 FY | -7.46 Million USD | -26.85% |
| 2017 Q4 | -3.58 Million AUD | 0.0% |
| 2017 Q2 | -3.72 Million USD | 0.0% |
| 2016 Q2 | -2 Million USD | 0.0% |
| 2016 FY | -5.88 Million USD | 13.19% |
| 2016 Q4 | -3.72 Million AUD | 0.0% |
| 2015 FY | -6.77 Million USD | -5.27% |
| 2015 Q4 | -3.26 Million AUD | 0.0% |
| 2015 Q2 | -3.73 Million USD | 0.0% |
| 2014 Q2 | -3.28 Million USD | 0.0% |
| 2014 Q4 | -2.97 Million AUD | 0.0% |
| 2014 FY | -6.43 Million USD | -1.29% |
| 2013 Q3 | -2.12 Million USD | 46.97% |
| 2013 FY | -6.35 Million USD | 29.4% |
| 2013 Q2 | -4.01 Million USD | -67.7% |
| 2013 Q1 | -2.39 Million USD | 0.0% |
| 2013 Q4 | -3.21 Million USD | -50.97% |
| 2012 FY | -9 Million USD | 31.42% |
| 2012 Q4 | - USD | 100.0% |
| 2012 Q3 | -2.39 Million USD | 1.92% |
| 2012 Q2 | -2.43 Million USD | 16.06% |
| 2012 Q1 | -2.9 Million USD | 0.0% |
| 2011 Q1 | -2.62 Million USD | 0.0% |
| 2011 Q3 | -3.08 Million USD | -3.95% |
| 2011 Q4 | - USD | 100.0% |
| 2011 FY | -13.12 Million USD | -79.51% |
| 2011 Q2 | -2.96 Million USD | -13.13% |
| 2010 Q3 | -2.48 Million USD | -3.18% |
| 2010 Q1 | -2.44 Million USD | 0.0% |
| 2010 FY | -7.31 Million USD | -8.12% |
| 2010 Q4 | - USD | 100.0% |
| 2010 Q2 | -2.41 Million USD | 1.17% |
| 2009 Q1 | -1.73 Million USD | 0.0% |
| 2009 Q3 | -1.94 Million USD | -7.22% |
| 2009 FY | -6.76 Million USD | 14.6% |
| 2009 Q4 | - USD | 100.0% |
| 2009 Q2 | -1.81 Million USD | -4.77% |
| 2008 Q3 | -2.05 Million USD | -2.02% |
| 2008 Q1 | -3.76 Million USD | 0.0% |
| 2008 Q2 | -2.01 Million USD | 46.42% |
| 2008 Q4 | - USD | 100.0% |
| 2008 FY | -7.91 Million USD | 34.92% |
| 2007 Q1 | -894.1 Thousand USD | 0.0% |
| 2007 Q4 | - USD | 100.0% |
| 2007 FY | -12.16 Million USD | -365.08% |
| 2007 Q2 | -3.3 Million USD | -269.79% |
| 2007 Q3 | -3.45 Million USD | -4.45% |
| 2006 FY | -2.61 Million USD | -49.62% |
| 2006 Q3 | -849.64 Thousand USD | 5.28% |
| 2006 Q2 | -896.98 Thousand USD | -55.88% |
| 2006 Q4 | - USD | 100.0% |
| 2006 Q1 | -575.42 Thousand USD | 0.0% |
| 2005 Q2 | -585.63 Thousand USD | -27.17% |
| 2005 Q3 | -583.36 Thousand USD | 0.39% |
| 2005 Q4 | - USD | 100.0% |
| 2005 FY | -1.74 Million USD | -39.31% |
| 2005 Q1 | -460.51 Thousand USD | 0.0% |
| 2004 Q3 | -484.43 Thousand USD | 0.93% |
| 2004 Q1 | -751.97 Thousand USD | 0.0% |
| 2004 Q4 | - USD | 100.0% |
| 2004 Q2 | -488.96 Thousand USD | 34.98% |
| 2004 FY | -1.25 Million USD | 37.72% |
| 2003 Q1 | -876.37 Thousand USD | 0.0% |
| 2003 Q2 | -647.15 Thousand USD | 26.16% |
| 2003 FY | -2.01 Million USD | 1.59% |
| 2003 Q3 | -661.12 Thousand USD | -2.16% |
| 2003 Q4 | - USD | 100.0% |
| 2002 Q1 | -191.23 Thousand USD | 0.0% |
| 2002 Q2 | -819.18 Thousand USD | -328.36% |
| 2002 Q4 | - USD | 100.0% |
| 2002 Q3 | -855.65 Thousand USD | -4.45% |
| 2002 FY | -2.04 Million USD | -31129.23% |
| 2001 Q2 | -213.96 Thousand USD | -163.97% |
| 2001 FY | -6557.87 USD | 98.0% |
| 2001 Q4 | - USD | 100.0% |
| 2001 Q3 | -190.48 Thousand USD | 10.97% |
| 2001 Q1 | 334.45 Thousand USD | 0.0% |
| 2000 FY | -328.56 Thousand USD | 33.21% |
| 2000 Q1 | 777.15 Thousand USD | 0.0% |
| 2000 Q4 | - USD | -100.0% |
| 2000 Q2 | 396.04 Thousand USD | -49.04% |
| 2000 Q3 | 373.82 Thousand USD | -5.61% |
| 1999 Q3 | 749.04 Thousand USD | 0.27% |
| 1999 Q1 | -294.52 Thousand USD | 3.65% |
| 1999 FY | -491.94 Thousand USD | -22.43% |
| 1999 Q2 | 747.05 Thousand USD | 353.65% |
| 1999 Q4 | - USD | -100.0% |
| 1998 Q4 | -305.67 Thousand USD | 7.87% |
| 1998 Q2 | -336.66 Thousand USD | -32.6% |
| 1998 Q3 | -331.77 Thousand USD | 1.45% |
| 1998 Q1 | -253.89 Thousand USD | 0.0% |
| 1998 FY | -401.8 Thousand USD | -106.82% |
| 1997 FY | -194.27 Thousand USD | -17.97% |
| 1997 Q2 | -268.05 Thousand USD | -24.64% |
| 1997 Q1 | -215.06 Thousand USD | -0.2% |
| 1997 Q3 | -274.24 Thousand USD | -2.31% |
| 1997 Q4 | - USD | 100.0% |
| 1996 Q4 | -214.64 Thousand USD | -1.03% |
| 1996 Q1 | -124.9 Thousand USD | -5.73% |
| 1996 FY | -164.67 Thousand USD | -70.33% |
| 1996 Q2 | -204.15 Thousand USD | -63.45% |
| 1996 Q3 | -212.44 Thousand USD | -4.06% |
| 1995 Q3 | -120.96 Thousand USD | 4.55% |
| 1995 Q2 | -126.73 Thousand USD | -1042.35% |
| 1995 Q1 | -11.09 Thousand USD | -1.58% |
| 1995 FY | -96.68 Thousand USD | -15.75% |
| 1995 Q4 | -118.13 Thousand USD | 2.34% |
| 1994 Q4 | -10.92 Thousand USD | -3.49% |
| 1994 Q3 | -10.55 Thousand USD | 0.8% |
| 1994 Q2 | -10.63 Thousand USD | 87.1% |
| 1994 Q1 | -82.45 Thousand USD | 3.57% |
| 1994 FY | -83.52 Thousand USD | -66.47% |
| 1993 Q4 | -85.5 Thousand USD | 4.5% |
| 1993 FY | -50.17 Thousand USD | -52.79% |
| 1993 Q2 | -86.32 Thousand USD | -518.06% |
| 1993 Q1 | -13.96 Thousand USD | 3.88% |
| 1993 Q3 | -89.53 Thousand USD | -3.72% |
| 1992 FY | -32.83 Thousand USD | 37.26% |
| 1992 Q1 | -34.66 Thousand USD | -3.93% |
| 1992 Q4 | -14.52 Thousand USD | 2.63% |
| 1992 Q3 | -14.92 Thousand USD | -2.31% |
| 1992 Q2 | -14.58 Thousand USD | 57.93% |
| 1991 Q1 | -127.48 Thousand USD | -4.87% |
| 1991 Q3 | -33.68 Thousand USD | 1.11% |
| 1991 FY | -52.33 Thousand USD | -735.92% |
| 1991 Q4 | -33.35 Thousand USD | 0.99% |
| 1991 Q2 | -34.06 Thousand USD | 73.28% |
| 1990 Q3 | -115.76 Thousand USD | 2.34% |
| 1990 FY | -6261.03 USD | -209.15% |
| 1990 Q1 | -103.96 Thousand USD | -2.5% |
| 1990 Q2 | -118.53 Thousand USD | -14.02% |
| 1990 Q4 | -121.55 Thousand USD | -5.0% |
| 1989 Q3 | -109.31 Thousand USD | 6.81% |
| 1989 Q4 | -101.42 Thousand USD | 7.21% |
| 1989 Q2 | -117.3 Thousand USD | 0.0% |
| 1989 FY | 5736.20 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | 19.124% |
| Alkermes plc | 414.12 Million USD | 146.325% |
| Agenus Inc. | -159.54 Million USD | -20.241% |
| Aptorum Group Limited | -10.52 Million USD | -1723.023% |
| Ardelyx, Inc. | -63.27 Million USD | -203.184% |
| Dyadic International, Inc. | -8.22 Million USD | -2231.091% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -15994.189% |
| Lantern Pharma Inc. | -17.87 Million USD | -973.092% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -854.926% |
| Novavax, Inc. | -566.51 Million USD | 66.136% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -162.874% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -133.397% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -887.937% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -1716.177% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -261.106% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 49.581% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -689.262% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -406.596% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -48.729% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -128.618% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -993.807% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -335.907% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -672.189% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -37.986% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | 32.013% |
| AlloVir, Inc. | -181.33 Million USD | -5.797% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | 6.419% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -555.693% |
| Bicycle Therapeutics plc | -189.94 Million USD | -0.999% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -11.678% |
| ChromaDex Corporation | -5.59 Million USD | -3326.375% |
| Chimerix, Inc. | -93.06 Million USD | -106.138% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -325.586% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -65.298% |
| CRISPR Therapeutics AG | -222.53 Million USD | 13.793% |
| Precision BioSciences, Inc. | -43.73 Million USD | -338.638% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -0.699% |
| Fortress Biotech, Inc. | -142.34 Million USD | -34.776% |
| Fortress Biotech, Inc. | -142.34 Million USD | -34.776% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -96.371% |
| ImmuCell Corporation | -5.74 Million USD | -3237.511% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -42.709% |
| Immix Biopharma, Inc. | -16.14 Million USD | -1088.535% |
| Incyte Corporation | 620.52 Million USD | 130.916% |
| Innoviva, Inc. | 176.7 Million USD | 208.564% |
| IO Biotech, Inc. | -91.44 Million USD | -109.795% |
| Jaguar Health, Inc. | -34.29 Million USD | -459.455% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -12.888% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 1706.454% |
| ContextLogic Inc. | -328 Million USD | 41.511% |
| MiMedx Group, Inc. | 37.11 Million USD | 616.873% |
| MEI Pharma, Inc. | 14.54 Million USD | 1419.232% |
| NextCure, Inc. | -67.63 Million USD | -183.636% |
| Onconetix, Inc. | -36.03 Million USD | -432.385% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -359.9% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -6871.473% |
| Vaxcyte, Inc. | -468.04 Million USD | 59.012% |
| PDS Biotechnology Corporation | -43.04 Million USD | -345.677% |
| Precigen, Inc. | -88.92 Million USD | -115.74% |
| Pharming Group N.V. | -4.87 Million USD | -3831.571% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -14.662% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -544.719% |
| PureTech Health plc | -146.19 Million USD | -31.22% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -836.229% |
| Avidity Biosciences, Inc. | -235.59 Million USD | 18.572% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -689.262% |
| Sangamo Therapeutics, Inc. | -274 Million USD | 29.986% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -554.642% |
| Acelyrin, Inc. | -422.06 Million USD | 54.547% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -1487636.531% |
| Summit Therapeutics Inc. | -89.73 Million USD | -113.786% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -417.599% |
| Senti Biosciences, Inc. | -92.72 Million USD | -106.89% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -67.15% |
| Elevation Oncology, Inc. | -45.44 Million USD | -322.143% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -459.847% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -4766.575% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -5967.133% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -480.972% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2156.708% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -182.138% |
| Seer, Inc. | -103.46 Million USD | -85.422% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -191.736% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -166.696% |
| ESSA Pharma Inc. | -32.13 Million USD | -497.007% |
| GlycoMimetics, Inc. | -39.27 Million USD | -388.457% |
| GT Biopharma, Inc. | -13.57 Million USD | -1313.102% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | 12.489% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -314.741% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 320.986% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -237.995% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -272.467% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -1830.465% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 61.96% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -2681.136% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -278.44% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | 26.117% |
| Aptose Biosciences Inc. | -52.35 Million USD | -266.42% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -1230.322% |
| Soligenix, Inc. | -7.69 Million USD | -2392.131% |
| Century Therapeutics, Inc. | -146.54 Million USD | -30.91% |
| Kura Oncology, Inc. | -165.8 Million USD | -15.705% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -105.272% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -2206.079% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -7630.485% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -2858.71% |
| Autolus Therapeutics plc | -195.02 Million USD | 1.633% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -126.612% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -160.436% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -807.702% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | 15.501% |
| GRI Bio, Inc. | -11.38 Million USD | -1584.752% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -4148.336% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -46.229% |
| IGM Biosciences, Inc. | -263.46 Million USD | 27.184% |
| INmune Bio, Inc. | -29.74 Million USD | -545.045% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -73.433% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -403.851% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1100.566% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -1116.441% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -213.992% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -78.422% |
| Atara Biotherapeutics, Inc. | -276 Million USD | 30.493% |
| Coherus BioSciences, Inc. | -203.19 Million USD | 5.589% |
| Verastem, Inc. | -92.08 Million USD | -108.334% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -307.007% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -4.18% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -62.057% |
| Histogen Inc. | -10.64 Million USD | -1702.525% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -1139.938% |
| Surrozen, Inc. | -45.78 Million USD | -319.054% |
| Organovo Holdings, Inc. | -15.08 Million USD | -1171.661% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -3668.838% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -223.613% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -274.006% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -658.872% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -2413.385% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -12.003% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -295.977% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -145.308% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -1160.401% |
| Apollomics, Inc. | -54.83 Million USD | -249.861% |
| Amarin Corporation plc | -67.58 Million USD | -183.841% |
| Mesoblast Limited | -58.79 Million USD | -226.296% |
| Turnstone Biologics Corp. | -59.03 Million USD | -224.981% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -15.896% |
| Synaptogenix, Inc. | -8.31 Million USD | -2207.507% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -1215.253% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -109.227% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -3903.842% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -2072.321% |
| Exelixis, Inc. | 170.88 Million USD | 212.264% |
| Better Therapeutics, Inc. | -38.26 Million USD | -401.392% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -23.719% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 62.902% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1524.813% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -2285.538% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -539.625% |
| Gritstone bio, Inc. | -154.63 Million USD | -24.062% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -178.594% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -1020.377% |
| Avid Bioservices, Inc. | -18.67 Million USD | -927.105% |
| Insmed Incorporated | -709.62 Million USD | 72.966% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -1122.724% |
| MediWound Ltd. | -15.29 Million USD | -1154.694% |
| OmniAb, Inc. | -69.41 Million USD | -176.355% |
| Alector, Inc. | -151.74 Million USD | -26.429% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -77.66% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -267.881% |
| Zai Lab Limited | -366.57 Million USD | 47.666% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 39.439% |
| Aura Biosciences, Inc. | -84.99 Million USD | -125.721% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | 21.856% |
| Immunic, Inc. | -99.22 Million USD | -93.345% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -34.008% |
| Veracyte, Inc. | -85.79 Million USD | -123.606% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | 31.926% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1250.054% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -2685.195% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -920.841% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 133.158% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -653.714% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 594.415% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1029.786% |
| Galecto, Inc. | -39.9 Million USD | -380.749% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -355.965% |
| Fortrea Holdings Inc. | 63.1 Million USD | 404.03% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -36.596% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -564.321% |
| XBiotech Inc. | -37.51 Million USD | -411.444% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -178.594% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -185.821% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -77.787% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -647.284% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -259.984% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 66.297% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -144.411% |
| Vaxxinity, Inc. | -58.28 Million USD | -229.146% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -84.982% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -762.093% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -121.999% |
| NexImmune, Inc. | -29.19 Million USD | -557.165% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -3313.492% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -1215.669% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 104.74% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -653.536% |
| Scopus BioPharma Inc. | -11.71 Million USD | -1537.599% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -50.984% |
| Ainos, Inc. | -13.2 Million USD | -1352.65% |
| Pluri Inc. | -22.15 Million USD | -765.794% |
| Prothena Corporation plc | -191.03 Million USD | -0.422% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -38.978% |
| Celularity Inc. | -192.28 Million USD | 0.231% |
| Rallybio Corporation | -78.93 Million USD | -143.048% |
| Cue Biopharma, Inc. | -52.14 Million USD | -267.874% |
| MeiraGTx Holdings plc | -137.06 Million USD | -39.969% |
| Omeros Corporation | -164.53 Million USD | -16.6% |
| Humacyte, Inc. | -100.04 Million USD | -91.753% |
| Immunocore Holdings plc | -59.64 Million USD | -221.619% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -933.691% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -683.575% |
| Blueprint Medicines Corporation | -486.27 Million USD | 60.549% |
| CalciMedica, Inc. | -21.87 Million USD | -776.995% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -156.955% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -45.905% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -11.996% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 41.315% |
| Pulmatrix, Inc. | -14.74 Million USD | -1201.511% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -436.698% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -115.879% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 62.77% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -183.997% |
| Cytokinetics, Incorporated | -496.2 Million USD | 61.338% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -457.375% |
| Nutriband Inc. | -4.87 Million USD | -3837.719% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -339.875% |
| Vor Biopharma Inc. | -126.03 Million USD | -52.213% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 104.522% |
| Evogene Ltd. | -26.39 Million USD | -626.925% |
| ProKidney Corp. | -151.52 Million USD | -26.61% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -197.269% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -2393.977% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 68.414% |
| CorMedix Inc. | -48.95 Million USD | -291.853% |
| BioLineRx Ltd. | -49.69 Million USD | -286.048% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -68.028% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -403.895% |
| Atai Life Sciences N.V. | -125.47 Million USD | -52.898% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -134.988% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -135.653% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | 22.951% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -524.082% |
| MediciNova, Inc. | -9.9 Million USD | -1837.754% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -51.807% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -2548.862% |
| GeoVax Labs, Inc. | -26.74 Million USD | -617.358% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | 17.247% |
| Biomea Fusion, Inc. | -126.13 Million USD | -52.093% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 45.094% |
| Mereo BioPharma Group plc | -28.41 Million USD | -575.122% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -0.394% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | 16.573% |
| Absci Corporation | -115.51 Million USD | -66.076% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -595.41% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -69.972% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | 20.779% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -661.402% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | 7.765% |
| Allakos Inc. | -196.05 Million USD | 2.149% |
| Imunon, Inc. | -21.03 Million USD | -812.215% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -73.356% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 278.821% |
| BioAtla, Inc. | -129.68 Million USD | -47.927% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1524.813% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -1110.899% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 41.464% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -359.416% |
| XOMA Corporation | -41.84 Million USD | -358.427% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -82.296% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -57.902% |
| aTyr Pharma, Inc. | -54.91 Million USD | -249.319% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -119.432% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -10.975% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | 24.605% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -793.705% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -2235.912% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1041.513% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -2169323.071% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 156.83% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -2836.059% |
| UroGen Pharma Ltd. | -65.53 Million USD | -192.729% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -114.882% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -2541.366% |
| Orgenesis Inc. | -53.63 Million USD | -257.675% |
| Entera Bio Ltd. | -8.89 Million USD | -2057.718% |
| GH Research PLC | -41.22 Million USD | -365.389% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -646.237% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -130.988% |
| Xencor, Inc. | -138.63 Million USD | -38.376% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -3621.79% |
| Replimune Group, Inc. | -234.77 Million USD | 18.286% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -792.66% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -1275.02% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -2836.059% |
| Portage Biotech Inc. | -18.25 Million USD | -951.02% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -2548.862% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -82.775% |
| OncoCyte Corporation | -25.13 Million USD | -663.219% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -1596.994% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -1574.45% |
| Purple Biotech Ltd. | 22.27 Million USD | 961.402% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -2453.817% |
| scPharmaceuticals Inc. | -55.39 Million USD | -246.312% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -915.165% |
| HilleVax, Inc. | -133.34 Million USD | -43.869% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -1492.188% |
| Tharimmune, Inc. | -9.45 Million USD | -1928.961% |
| Genprex, Inc. | -31.07 Million USD | -517.343% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -1.939% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -511.412% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -24977.481% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -3422.041% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1217969.98% |
| Savara Inc. | -60 Million USD | -219.701% |
| Curis, Inc. | -48.33 Million USD | -296.927% |
| Daré Bioscience, Inc. | -30.83 Million USD | -522.061% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -3577.064% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -2536.289% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -604.01% |
| BeiGene, Ltd. | -1.2 Billion USD | 84.116% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -862.134% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 60.622% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -104.846% |
| Erasca, Inc. | -141.52 Million USD | -35.554% |
| bluebird bio, Inc. | -244.26 Million USD | 21.46% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -4137.77% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 198.664% |
| DBV Technologies S.A. | -76.43 Million USD | -150.998% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -4137.77% |
| Moderna, Inc. | -4.23 Billion USD | 95.474% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -350.24% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -2916.395% |
| Molecular Templates, Inc. | -10.46 Million USD | -1733.009% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -185.323% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 49.079% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -33.865% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -268.978% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -24.136% |
| Cogent Biosciences, Inc. | -208.13 Million USD | 7.826% |
| MacroGenics, Inc. | -168.24 Million USD | -14.026% |
| RenovoRx, Inc. | -11.39 Million USD | -1583.422% |
| Adicet Bio, Inc. | -152.03 Million USD | -26.181% |
| Prime Medicine, Inc. | -191.29 Million USD | -0.288% |
| Aditxt, Inc. | -26.06 Million USD | -636.089% |
| Adagene Inc. | -23.71 Million USD | -708.785% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2524.352% |
| Quantum-Si incorporated | -111.17 Million USD | -72.565% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -506.176% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1215.995% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 257.23% |
| SciSparc Ltd. | -5.77 Million USD | -3223.103% |
| Vericel Corporation | -6.46 Million USD | -2867.864% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -2116.128% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -729.785% |
| Generation Bio Co. | -138.56 Million USD | -38.452% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -131.052% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -121.886% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | 20.431% |
| Invivyd, Inc. | -207.78 Million USD | 7.672% |
| Relay Therapeutics, Inc. | -373 Million USD | 48.568% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -1945.558% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 993.081% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -1764.905% |
| 2seventy bio, Inc. | -216.7 Million USD | 11.472% |
| ADMA Biologics, Inc. | 21.63 Million USD | 986.847% |
| Clene Inc. | -40.54 Million USD | -373.218% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -696.76% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -250.104% |
| GeoVax Labs, Inc. | -26.74 Million USD | -617.358% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 45.197% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -422.277% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 1293.274% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -84.994% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -464.21% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -12.664% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 71.965% |
| Evaxion Biotech A/S | -22.19 Million USD | -764.273% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -132.87% |
| Verve Therapeutics, Inc. | -223.12 Million USD | 14.02% |
| Trevena, Inc. | -35.28 Million USD | -443.649% |
| Surrozen, Inc. | -45.78 Million USD | -319.054% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -139.968% |
| Cingulate Inc. | -22.75 Million USD | -742.924% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 2660.634% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -329.495% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -2229.902% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -87.058% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -161.441% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -209.055% |
| Clearmind Medicine Inc. | -8.74 Million USD | -2094.658% |
| Kronos Bio, Inc. | -121.83 Million USD | -57.468% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -151.775% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -6440.87% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -90.269% |
| Statera Biopharma, Inc. | -98.34 Million USD | -95.074% |
| ImmunityBio, Inc. | -362.25 Million USD | 47.041% |
| Korro Bio, Inc. | -84.53 Million USD | -126.942% |
| Kineta, Inc. | -15.72 Million USD | -1120.141% |
| BioVie Inc. | -32.17 Million USD | -496.163% |
| Codexis, Inc. | -68.06 Million USD | -181.836% |
| Celularity Inc. | -192.28 Million USD | 0.231% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | 13.82% |
| Celcuity Inc. | -66.23 Million USD | -189.66% |
| Virax Biolabs Group Limited | -6.49 Million USD | -2853.029% |
| Cibus, Inc. | -318.88 Million USD | 39.839% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -346.146% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -466.844% |
| IN8bio, Inc. | -30.33 Million USD | -532.372% |
| Kodiak Sciences Inc. | -277.32 Million USD | 30.823% |
| Annexon, Inc. | -143.72 Million USD | -33.481% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -54.973% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -196.759% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -718.302% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 45.766% |
| Eyenovia, Inc. | -25.4 Million USD | -655.095% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 687.753% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -3349.168% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -142.431% |
| Arcellx, Inc. | -89.88 Million USD | -113.443% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -322.449% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -39.82% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -516.679% |
| Moolec Science SA | -6.65 Million USD | -2783.203% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -213.786% |
| Geron Corporation | -193.94 Million USD | 1.083% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -343.536% |
| Royalty Pharma plc | 1.49 Billion USD | 112.857% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -16.862% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -1956.663% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -776.208% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -12.217% |
| Humacyte, Inc. | -100.04 Million USD | -91.753% |
| Structure Therapeutics Inc. | -102.77 Million USD | -86.663% |
| 89bio, Inc. | -151.2 Million USD | -26.877% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -139.408% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -1219.414% |
| Genelux Corporation | -24.16 Million USD | -693.887% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -465.524% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -11.699% |
| Notable Labs, Ltd. | -14.65 Million USD | -1208.881% |
| Liquidia Corporation | -73.38 Million USD | -161.423% |
| Mustang Bio, Inc. | -50.72 Million USD | -278.194% |
| Immunovant, Inc. | -282.7 Million USD | 32.141% |
| Quantum-Si incorporated | -111.17 Million USD | -72.565% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -145.628% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -802.068% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -88.059% |
| Acasti Pharma Inc. | -11.31 Million USD | -1595.922% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -736.97% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1100.566% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | 10.376% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -5128.645% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1107.621% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -557.965% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -363.567% |
| PepGen Inc. | -84.76 Million USD | -126.32% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -547.439% |
| United Therapeutics Corporation | 1.18 Billion USD | 116.191% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -737.851% |
| Solid Biosciences Inc. | -104.31 Million USD | -83.907% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -484.742% |
| Immuneering Corporation | -58.41 Million USD | -228.425% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -3668.838% |
| Silo Pharma, Inc. | -3.85 Million USD | -4875.701% |
| Belite Bio, Inc | -31.66 Million USD | -505.794% |
| XOMA Corporation | -41.84 Million USD | -358.427% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -184.127% |
| Bionomics Limited | -17.89 Billion USD | 98.928% |
| Apogee Therapeutics, Inc. | -93 Million USD | -106.276% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 637.676% |
| uniQure N.V. | -282.87 Million USD | 32.18% |
| Cassava Sciences, Inc. | -105.95 Million USD | -81.057% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2524.352% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -48.137% |
| Forte Biosciences, Inc. | -32.48 Million USD | -490.54% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -2208.923% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -552.637% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -3349.168% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1250.054% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -2058.204% |
| Altimmune, Inc. | -95.92 Million USD | -99.984% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -161.032% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 637.676% |
| Compugen Ltd. | -12.99 Million USD | -1376.622% |
| Peak Bio, Inc. | -1356.23 USD | -14145194.898% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -286.749% |
| Benitec Biopharma Inc. | -22.49 Million USD | -753.013% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 20.825% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -544.936% |
| Zura Bio Limited | -62.63 Million USD | -206.272% |
| PolyPid Ltd. | -22.86 Million USD | -738.95% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -1078.685% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -544.936% |
| Instil Bio, Inc. | -159.16 Million USD | -20.528% |
| argenx SE | -425.04 Million USD | 54.866% |
| Immunome, Inc. | -109.53 Million USD | -75.151% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -280.92% |
| Verona Pharma plc | -67.83 Million USD | -182.825% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -636.158% |
| Shattuck Labs, Inc. | -91.95 Million USD | -108.622% |
| CervoMed Inc. | -7.81 Million USD | -2355.463% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -162.403% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -1340.153% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -298.229% |
| Moolec Science SA | -6.65 Million USD | -2783.203% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -1066.328% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -41.868% |
| AnaptysBio, Inc. | -164.41 Million USD | -16.685% |
| Design Therapeutics, Inc. | -78.19 Million USD | -145.355% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -120.405% |
| NeurAxis, Inc. | -6.66 Million USD | -2778.579% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -373.697% |
| Lumos Pharma, Inc. | -36.61 Million USD | -423.96% |
| Achilles Therapeutics plc | -75.25 Million USD | -154.924% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -636.158% |
| 180 Life Sciences Corp. | -13.47 Million USD | -1323.43% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 3820.542% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -6440.87% |
| Nutriband Inc. | -4.87 Million USD | -3837.719% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -73.175% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -245.981% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -277.376% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -190.235% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -254.456% |
| Palisade Bio, Inc. | -13.07 Million USD | -1367.81% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -322.477% |
| Beam Therapeutics Inc. | -176.48 Million USD | -8.702% |
| Neurogene Inc. | -55.58 Million USD | -245.146% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -75.754% |
| AEON Biopharma, Inc. | -48.42 Million USD | -296.132% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -98.369% |
| Sesen Bio, Inc. | -25.9 Million USD | -640.448% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -129.672% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -1424.146% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 58.346% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -164.833% |
| Athira Pharma, Inc. | -125.46 Million USD | -52.904% |
| Vaccinex, Inc. | -22.88 Million USD | -738.29% |
| HCW Biologics Inc. | -25.71 Million USD | -645.972% |
| XOMA Corporation | -41.84 Million USD | -358.427% |
| Nektar Therapeutics | -137.42 Million USD | -39.598% |
| Arvinas, Inc. | -401.5 Million USD | 52.218% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -2169323.071% |
| Merus N.V. | -156.54 Million USD | -22.546% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -91.343% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -454.138% |
| Rezolute, Inc. | -70.42 Million USD | -172.415% |
| Clene Inc. | -40.54 Million USD | -373.218% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -1071.31% |
| BeyondSpring Inc. | -23.11 Million USD | -729.985% |
| Synlogic, Inc. | -55.16 Million USD | -247.787% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -970.014% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -1672.383% |
| Peak Bio, Inc. | -1356.23 USD | -14145194.898% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -373.651% |
| Krystal Biotech, Inc. | -109.72 Million USD | -74.836% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -48.095% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 44.071% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -3942.238% |
| MannKind Corporation | 8.67 Million USD | 2310.679% |
| Ikena Oncology, Inc. | -75.41 Million USD | -154.376% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -1888.626% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -185.353% |
| Gossamer Bio, Inc. | -183.75 Million USD | -4.399% |
| CohBar, Inc. | -12.38 Million USD | -1448.58% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -278.209% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -595.41% |
| Legend Biotech Corporation | -439.48 Million USD | 56.348% |
| Mural Oncology plc | -194.63 Million USD | 1.436% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -185.723% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1088.229% |
| Disc Medicine, Inc. | -91.12 Million USD | -110.527% |
| Champions Oncology, Inc. | -7.35 Million USD | -2507.976% |
| REGENXBIO Inc. | -268.12 Million USD | 28.451% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -1689.88% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -244.075% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -392.401% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -67.758% |
| Vaxart, Inc. | -83.34 Million USD | -130.174% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -2151.673% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -348.293% |
| Cellectis S.A. | -106.62 Million USD | -79.921% |
| Longeveron Inc. | -21.02 Million USD | -812.277% |
| Repare Therapeutics Inc. | -116.22 Million USD | -65.063% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | 28.37% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -153.609% |
| Revolution Medicines, Inc. | -487.18 Million USD | 60.622% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -2783.986% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -336.463% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -157.196% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -175.498% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -1642.283% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 104.454% |
| Denali Therapeutics Inc. | -196.69 Million USD | 2.469% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -2116.128% |
| Veru Inc. | -93.78 Million USD | -104.562% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -722.336% |
| Cingulate Inc. | -22.75 Million USD | -742.924% |
| Passage Bio, Inc. | -108.38 Million USD | -76.995% |
| Context Therapeutics Inc. | -25.07 Million USD | -665.148% |
| Exicure, Inc. | -14.99 Million USD | -1179.293% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 6.901% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -372.542% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -1874.313% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -4.06% |
| Nuvalent, Inc. | -149.49 Million USD | -28.33% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -2234.845% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -116.207% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -823.475% |
| OmniAb, Inc. | -69.41 Million USD | -176.355% |
| Anew Medical, Inc. | -1.3 Million USD | -14647.604% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -1402.175% |
| Lipocine Inc. | -17.93 Million USD | -969.897% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -180.009% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -151.921% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -403.851% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -385.346% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -757.053% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 66.915% |
| Ocugen, Inc. | -65.53 Million USD | -192.751% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -104.379% |
| Q32 Bio Inc. | -92.1 Million USD | -108.294% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -794.831% |
| Alumis Inc. Common Stock | -158.17 Million USD | -21.286% |
| Equillium, Inc. | -14.52 Million USD | -1221.049% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -207.411% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -2327.36% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -916.918% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -308.602% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -76.869% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -1502.694% |
| Dominari Holdings Inc. | -21.79 Million USD | -780.174% |
| Edesa Biotech, Inc. | -9.22 Million USD | -1980.102% |
| vTv Therapeutics Inc. | -25.5 Million USD | -652.265% |
| Bio-Techne Corporation | 206.68 Million USD | 192.818% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 50.996% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 199.902% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -45.031% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -399.708% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -26.963% |
| Nkarta, Inc. | -131.65 Million USD | -45.722% |
| BioCardia, Inc. | -11.64 Million USD | -1547.567% |
| Iterum Therapeutics plc | -47.46 Million USD | -304.152% |